Vision Point Advisory Group, LLC Becton Dickinson & CO Transaction History

Vision Point Advisory Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$225.07 - $246.17 $5,401 - $5,908	-24 Reduced 51.06%	23 $5,000
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $2,567 - $2,725	-11 Reduced 18.97%	47 $11,000
Q4 2023 Feb 07, 2024	BUY	$232.24 - $267.23 $5,573 - $6,413	24 Added 70.59%	58 $14,000
Q2 2023 Aug 21, 2023	BUY	$238.39 - $265.32 $8,105 - $9,020	34 New	34 $8,000
Q4 2020 Feb 08, 2021	SELL	$221.92 - $245.94 $212,377 - $235,364	-957 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $36,680 - $47,049	-170 Reduced 15.08%	957 $223,000
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $8,136 - $9,746	37 Added 3.39%	1,127 $307,000
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $213,302 - $304,120	1,090 New	1,090 $251,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.